Merck Subsidiary Buys Teqqa, Aims to Support Hospitals in Improving Outcomes for Patients with Infectious Diseases

Like
Like Love Haha Wow Sad Angry

Aims to Support Hospitals in Improving Outcomes for Patients ILÚM Health Solutions, created by Merck’s Healthcare Services and Solutions division, has now announced its acquisition of Teqqa LLC, which provides precision analytics for infectious disease management. “This acquisition helps reinforce ILÚM’s vision to transform the way hospitals manage infectious diseases,” said ILÚM Managing Director Paul […]

The post Merck Subsidiary Buys Teqqa, Aims to Support Hospitals in Improving Outcomes for Patients with Infectious Diseases appeared first on BioTecNika .Read more at www.biotecnika.org/2018/05/merck-subsidiary-buys-teqqa-aims-to-support-hospitals-in-improving-outcomes-for-patients-with-infectious-diseases/

Like
Like Love Haha Wow Sad Angry

Related posts